Automated spinal fluid drainage device during lumbar drain trials in normal pressure hydrocephalus
Tests an automated fluid drainage device in people with normal pressure hydrocephalus.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 14 May 2026
- Planned end
- 31 Oct 2026
- Type of study
- Interventional
- Treatments tested
- Intellidrop Automated CSF Drainage System
- Record updated
- 2 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 60 or older with suspected iNPH (normal pressure hydrocephalus, fluid build-up in the brain). They must be admitted to hospital for a lumbar drain trial (LDT). The LDT checks whether a shunt could help them.
- Age
- 60 Years to 99 Years
- Sex
- All
- Disease stage
- Suspected idiopathic normal pressure hydrocephalus (iNPH).
Main reasons for not taking part
- Under 18 years of age
- Pregnant
- Currently in prison
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All patients will be adults aged 60 years or older with suspected iNPH who are being admitted to the hospital for the purpose of an LDT specifically to evaluate for benefit from shunt placement
Who cannot take part
- Patients who are under 18 years of age, pregnant, or are currently incarcerated will be excluded from participating in this study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 60 and 99 years old?
Where in United States
- UT Southwestern Medical CenterDallas, United StatesContact: Maria DenbowTaking people
About the trial
What the trial wants to find out
The intellidrop device is an FDA-approved system that automates safe, small volume of cerebral spinal fluid drainage with continuous pressure monitoring, reducing nursing workload and human error while improving patient mobility and comfort
The group in the trial
- Experimental - Intellidrop Automated CSF Drainage SystemTreatment being tested
Device
Treatment: Intellidrop Automated CSF Drainage System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials
- Plain-language title
- Automated spinal fluid drainage device during lumbar drain trials in normal pressure hydrocephalusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07494812, who can take part
- Record updated
- 2 June 2026